Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
With a market cap of 77.98B, Regeneron(REGN) trades at $737.71. The stock has a price-to-earnings ratio of 17.78 and currently yields dividends of 48.5%.
On 2026-03-28, Regeneron(REGN) stock traded between a low of $736.64 and a high of $759.47. Shares are currently priced at $737.71, which is +0.1% above the low and -2.9% below the high.
The Regeneron(REGN)'s current trading volume is 489.32K, compared to an average daily volume of 607.19K.
During the past year, Regeneron(REGN) stock moved between $476.49 at its lowest and $821.11 at its peak.
During the past year, Regeneron(REGN) stock moved between $476.49 at its lowest and $821.11 at its peak.
REGN News
AstraZeneca reported that its antibody drug tozorakimab succeeded in two Phase 3 trials in chronic obstructive pulmonary disease (COPD), targeting a broad COPD...
Key Points The company is slowly recovering from recent headwinds. It could perform well through the next five to 10 years. 10 stocks we like better than Reg...
Regeneron Pharmaceuticals and Sanofi recently received Japanese Ministry of Health, Labour and Welfare approval for Dupixent as the first targeted treatment for...
Analyst ratings
77%
of 30 ratingsMore REGN News
Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare, or MHLW, in Japan has approved Dupixent for the treatment of adults...
Rhythm Grabs A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat' 3/20/2026 Rhythm Pharmaceuticals stock ultimately closed down Friday,...
Advertisement Recent performance context Regeneron Pharmaceuticals (REGN) has recently drawn investor attention after a period of weaker share performance, wi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.